IL-6 Prevents T Cell-Mediated Hepatitis via Inhibition of NKT Cells in CD4+ T Cell- and STAT3-Dependent Manners

Journal of Immunology

Volumn 172, Issue 9, 2004, Pages 5648-5655

  Sun, Rui ^a,b   Tian, Zhigang ^b   Kulkarni, Shalini ^a   Gao, Bin ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; INTERLEUKIN 6; JANUS KINASE; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DIMERIZATION; DNA DAMAGE; ENDOTHELIUM CELL; ENZYME ACTIVATION; HEPATITIS; LIVER PROTECTION; LIVER REGENERATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; WILD TYPE;

EID: 2142764513     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.9.5648     Document Type: Article

References (42)

1. Cressman, D. E., L. E. Greenbaum, R. A. DeAngelis, G. Ciliberto, E. E. Furth, V. Poli, and R. Taub. 1996. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274:1379.
2. Hong, F., B. Jaruga, W. H. Kim, S. Radaeva, O. N. El-Assal, Z. Tian, V. A. Nguyen, and B. Gao. 2002. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J. Clin. Invest. 110:1503.
3. Mizuhara, H., M. Uno, N. Seki, M. Yamashita, M. Yamaoka, T. Ogawa, K. Kaneda, T. Fujii, H. Senoh, and H. Fujiwara. 1996. Critical involvement of interferon γ in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatology 23:1608.
4. L proteins. Oncogene 21:32.
5. L. J. Biol. Chem. 276:26605.
6. Kovalovich, K., R. A. DeAngelis, W. Li, E. E. Furth, G. Ciliberto, and R. Taub. 2000. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 31:149.
7. Camargo, C. A., Jr., J. F. Madden, W. Gao, R. S. Selvan, and P. A. Clavien. 1997. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 26:1513.
8. Masubuchi, Y., M. Bourdi, T. P. Reilly, M. L. Graf, J. W. George, and L. R. Pohl. 2003. Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease. Biochem. Biophys. Res. Commun. 304:207.
9. Meng, Z. H., K. Dyer, T. R. Billiar, and D. J. Tweardy. 2000. Distinct effects of systemic infusion of G-CSF vs. IL-6 on lung and liver inflammation and injury in hemorrhagic shock. Shock 14:41.
10. Selzner, N., M. Selzner, Y. Tian, Z. Kadry, and P. A. Clavien. 2002. Cold ischemia decreases liver regeneration after partial liver transplantation in the rat: a TNF-α/IL-6-dependent mechanism. Hepatology 36:812.
11. Sun, Z., A. S. Klein, S. Radaeva, F. Hong, O. El-Assal, H. N. Pan, B. Jaruga, S. Batkai, S. Hoshino, Z. Tian, G. Kunos, A. M. Diehl, and B. Gao. 2003. In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. Gastroenterology 125:202.
12. Chen, R. H., M. C. Chang, Y. H. Su, Y. T. Tsai, and M. L. Kuo. 1999. Interleukin-6 inhibits transforming growth factor-β-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways. J. Biol. Chem. 274:23013.
13. Li, W., X. Liang, C. Kellendonk, V. Poli, and R. Taub. 2002. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J. Biol. Chem. 277:28411.
14. Wuestefeld, T., C. Klein, K. L. Streetz, U. Betz, J. Lauber, J. Buer. M. P. Manns, W. Muller, and C. Trautwein. 2003. Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration. J. Biol. Chem. 278:11281.
15. Streetz, K. L., F. Tacke, L. Leifeld, T. Wustefeld, A. Graw, C. Klein, K. Kamino, U. Spengler, H. Kreipe, S. Kubicka, et al. 2003. Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases. Hepatology 38:218.
16. Streetz, K. L., T. Wustefeld, C. Klein, K. J. Kallen, F. Tronche, U. A. Betz, G. Schutz, M. P. Manns, W. Muller, and C. Trautwein. 2003. Lack of gp130 expression in hepatocytes promotes liver injury. Gastroenterology 125:532.
17. Taub, R. 2003. Hepatoprotection via the IL-6/Stat3 pathway. J. Clin. Invest. 112:978.
18. Haga, S., K. Terui, H. Q. Zhang, S. Enosawa, W. Ogawa, H. Inoue, T. Okuyama, K. Takeda, S. Akira, T. Ogino, et al. 2003. Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J. Clin. Invest. 112:989.
19. Tiegs, G., J. Hentschel, and A. Wendel. 1992. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90:196.
20. Takeda, K., Y. Hayakawa, L. Van Kaer, H. Matsuda, H. Yagita, and K. Okumura. 2000. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc. Natl. Acad. Sci. USA 97:5498.
21. Kaneko, Y., M. Harada, T. Kawano, M. Yamashita, Y. Shibata, F. Gejyo, T. Nakayama, and M. Taniguchi. 2000. Augmentation of Vα14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 191:105.
22. + T cells for concanavalin A-induced hepatic injury in mice. J. Immunol. 159:1537.
23. Jaruga, B., F. Hong, R. Sun, S. Radaeva, and B. Gao, 2003. Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes. J. Immunol. 171:3233.
24. + regulatory T cells suppress NKT cell functions. Cancer Res. 63:4516.
25. + T cells lose NK1.1 expression upon in vitro activation. J. Immunol. 158:5112.
26. Emoto, M., and S. H. Kaufmann. 2003. Liver NKT cells: an account of heterogeneity. Trends Immunol. 24:364.
27. Harada, M., K. I. Seino, H. Wakao, S. Sakata, Y. Ishizuka, T. Ito, S. Kojo, T. Nakayama, and M. Taniguchi. 2004. Down-regulation of the invariant Vα14 antigen receptor in NKT cells upon activation. Int. Immunol. 16:241.
28. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389.
29. Maloy, K. J., and F. Powrie. 2001. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2:816.
30. Takeda, K., T. Kaisho, N. Yoshida, J. Takeda, T. Kishimoto, and S. Akira. 1998. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J. Immunol. 161:4652.
31. Kronenberg, M., and L. Gapin. 2002. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2:557.
32. Bendelac, A., M. N. Rivera, S. H. Park, and J. H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535.
33. Crispe, I. N. 2003. Hepatic T cells and liver tolerance. Nat. Rev. Immunol. 3:51.
34. Shimizu, H., T. Matsuguchi, Y. Fukuda, I. Nakano, T. Hayakawa, O. Takeuchi, S. Akira, M. Umemura, T. Suda, and Y. Yoshikai. 2002. Toll-like receptor 2 contributes to liver injury by Salmonella infection through Fas ligand expression on NKT cells in mice. Gastroenterology 123:1265.
35. Ito, H., K. Ando, T. Nakayama, M. Taniguchi, T. Ezaki, K. Saito, M. Takemura, K. Sekikawa, M. Imawari, M. Seishima, et al. 2003. Role of Vα14 NKT cells in the development of impaired liver regeneration in vivo. Hepatology 38:1116.
36. Osman, Y., T. Kawamura, T. Naito, K. Takeda, L. Van Kaer, K. Okumura, and T. Abo. 2000. Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide. Eur. J. Immunol. 30:1919.
37. Abe, T., H. Kawamura, S. Kawabe, H. Watanabe, F. Gejyo, and T. Abo. 2002. Liver injury due to sequential activation of natural killer cells and natural killer T cells by carrageenan. J. Hepatol. 36:614.
38. Kakimi, K., L. G. Guidotti, Y. Koezuka, and F. V. Chisari. 2000. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192:921.
39. Lucas, M., S. Gadola, U. Meier, N. T. Young, G. Harcourt, A. Karadimitris, N. Coumi, D. Brown, G. Dusheiko, V. Cerundolo, et al. 2003. Frequency and phenotype of circulating Vα24/Vβ11 double-positive natural killer T cells during hepatitis C virus infection. J. Virol. 77:2251.
40. Exley, M. A., Q. He, O. Cheng, R. J. Wang, C. P. Cheney, S. P. Balk, and M. J. Koziel. 2002. Cutting edge: compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver. J. Immunol. 168:1519.
41. Kenna, T., L. G. Mason, S. A. Porcelli, Y. Koezuka, J. E. Hegarty, C. O'Farrelly, and D. G. Doherty. 2003. NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells. J. Immunol. 171:1775.
42. + NK cells in vitro. J. Immunol. 165:1659.